Barclays analyst Matt Miksic initiates coverage on Medtronic, Inc. (NYSE: MDT) with a Equalweight rating and a price target of $95.00.

For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.

Shares of Medtronic, Inc. closed at $87.97 yesterday.